Fresenius Medical Care AG & Co. KGaA
NYSE:FMSMedical - Care Facilities
-$0.18 today
- Market cap
- $11.26B
- Beta
- 0.81
- P/E (TTM)
- 11.9
- EPS (TTM)
- $3.43
- Dividend yield
- 3.65%
Volume 1.92M
Average 0.72M
FMS Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Fresenius Medical Care AG & Co. KGaANYSE: FMS
Short-term Debt · Q2 FY2026 · quarter ended Jun 2026
Short-term debt rises 71.8% from a year ago
Short-term debt stood at €1.74B at the end of Q2 FY2026, up 71.8% from a year earlier and down 3.0% from the prior quarter. Over 3 fiscal years it compounded at +6.3% a year.
Context
- Short-term debt amounted to 5.6% of total assets at the end of Q2 FY2026, up 2.3 pp from a year earlier.
- Short-term debt increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term debt keeps rising in the next quarterly balance sheet after a +71.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
EUR · from the balance sheet
- Latest · FY2025
- 1.61B EUR
- Year-over-year change
- +179.4%
- 4-year CAGR
- -4.3%
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.61B | +179.4% |
| FY2024 | 2024-12-31 | 577.38M | -38.9% |
| FY2023 | 2023-12-31 | 944.6M | -29.7% |
| FY2022 | 2022-12-31 | 1.34B | -30.2% |
| FY2021 | 2021-12-31 | 1.92B | — |
Short-term Debt vs competitors
How FMS compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +71.8% is the highest of 2, against a peer median of -35.8%.
- Short-term debt amounts to 5.6% of total assets for FMS, versus a peer median of 0.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | €1.74B EUR | +71.8% | +6.3% | 5.6% | |
| Jun 2026 | $117.18M USD | -35.8% | -22.1% | 0.7% | |
| Mar 2026 | $12.5M USD | — | +7.8% | 3.4% | |
| Sep 2026 | $6.31M USD | — | — | 0.7% | |
| Peer median (excluding FMS) | — | -35.8% | -7.2% | 0.7% | |
Competitors are the stored peer set for FMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.48B | 1.27B | 1.4B | 1.18B | 1.6B |
| Short-term Investments | 159.18M | 187.83M | 154.37M | 163.09M | 0 |
| Net Receivables | 3.58B | 3.72B | 3.64B | 3.41B | 3.14B |
| Inventory | 2.04B | 2.3B | 2.18B | 2.07B | 2.14B |
| Other Current Assets | 672.58M | 682.6M | 1.28B | 1.06B | 1.02B |
| Total Current Assets | 7.97B | 8.2B | 8.7B | 7.92B | 7.9B |
| Property, Plant & Equipment (Net) | 8.55B | 8.34B | 7.45B | 7.26B | 3.01B |
| Goodwill | 14.36B | 15.79B | 14.65B | 15.17B | 0 |
| Intangible Assets | 1.46B | 1.52B | 1.36B | 1.37B | 14.83B |
| Long-term Investments | 786.91M | 1.2B | 1.08B | 1.12B | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.24B | 702.46M | 681.83M | 720.02M | 5.26B |
| Total Non-current Assets | 26.4B | 27.55B | 25.23B | 25.64B | 23.1B |
| Total Assets | 34.37B | 35.75B | 33.93B | 33.57B | 31B |
| Account Payables | 857.53M | 951.58M | 885.15M | 984.32M | 738M |
| Short-term Debt | 1.92B | 1.34B | 944.6M | 577.38M | 1.61B |
| Tax Payables | 265.13M | 267.87M | 331.86M | 282.64M | 0 |
| Deferred Revenue | 518.03M | 105.72M | 85.82M | 82.17M | 0 |
| Other Current Liabilities | 2.75B | 2.86B | 2.99B | 2.84B | 3.31B |
| Total Current Liabilities | 7.26B | 6.47B | 6.11B | 5.66B | 6.25B |
| Long-term Debt | 6.65B | 7.17B | 6.96B | 6.26B | 5.69B |
| Deferred Tax Liabilities | 868.45M | 936.48M | 750.29M | 708.89M | 0 |
| Deferred Revenue (Non-current) | 0 | 9.47M | 13.87M | 34.02M | 0 |
| Other Non-current Liabilities | 1.53B | 1.72B | 1.74B | 1.63B | 1.88B |
| Total Non-current Liabilities | 13.13B | 13.84B | 12.99B | 12.14B | 10.47B |
| Total Liabilities | 20.39B | 20.3B | 19.1B | 17.8B | 16.72B |
| Common Stock | 293M | 293.41M | 293.41M | 293.41M | 14.28B |
| Retained Earnings | 10.83B | 10.71B | 10.92B | 11.27B | 0 |
| Accumulated OCI | (1.31B) | (388.47M) | (975.17M) | (328.55M) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.28B | 1.46B | 1.21B | 1.19B | 0 |
| Total Equity | 13.98B | 15.45B | 14.83B | 15.77B | 14.28B |
| Total Debt | 13.32B | 13.21B | 12.08B | 11B | 10.8B |
| Net Debt | 11.84B | 11.94B | 10.67B | 9.82B | 9.2B |
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.